IGFBPL1 and cancer: The inactivation of IGFBPL1 is associated with the pathogenesis of breast cancer [14]; moreover, IGFBPL1 inhibits the growth of cancer cell by inhibiting the signaling pathway PI3K-AKT in esophageal cancer [15].